CPA
ASTH icon

Capital Performance Advisors’s Astrana Health ASTH Stock Holding History

Capital Performance Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12
Closed -$695 – 2788
2024
Q3 		$695 Buy
+12
New +$590 ﹤0.01% 2090

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Performance Advisors's ASTH Position: Q4 2024 in Review

Capital Performance Advisors sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 12 shares — an estimated $695 sold.

Capital Performance Advisors first reported a position in ASTH in Q3 2024 and held it in 1 quarter. The position peaked at $695 in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Capital Performance Advisors reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 12 Astrana Health shares in Q4 2024, an estimated $695.
  • Capital Performance Advisors first reported a position in Astrana Health in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Astrana Health position peaked at $695 in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.